Management of Renal Stones >2 cm in the Modern Endourology Era: Does PCNL Remain the Gold Standard?
- 1Urology Department, Barzilai Medical Center, Ben-Gurion University of the Negev, Ashkelon 8410501, Israel
Abstract
Background: Percutaneous nephrolithotomy (PCNL) remains the reference treatment for renal stones larger than 2 cm because of its high single-session stone-free rate. However, advances in flexible ureteroscopy (fURS), laser lithotripsy, suction-assisted access systems, and endoscopic technology have expanded the role of retrograde intrarenal surgery (RIRS) in patients who historically would have been treated primarily with PCNL. Objective: To critically review the contemporary roles of PCNL and RIRS in the management of renal stones >2 cm and evaluate whether advances in endoscopic and laser technologies have altered the traditional treatment paradigm. Methods: A focused narrative review of the contemporary literature was performed using PubMed, Scopus, and Web of Science. Priority was given to randomized trials, prospective comparative studies, multicenter registries, systematic reviews, meta-analyses, and international guideline recommendations evaluating efficacy, safety, retreatment, operative burden, and technological developments relevant to the management of large renal stones. Results: PCNL continues to provide the most reliable single-session stone clearance for large and complex renal calculi, particularly in patients with high stone burden and staghorn disease. RIRS offers lower procedural morbidity and faster recovery but may require staged procedures as stone burden increases. Recent developments, including thulium fiber laser, pulse-modulated Holmium:YAG systems, suction-assisted ureteral access sheaths, improved digital ureteroscopy, and intrarenal pressure-control strategies, have increased the efficiency and potential applicability of RIRS for larger stones. Nevertheless, current evidence does not support replacing PCNL as the reference treatment for complex or high-volume stone disease. Conclusion: PCNL remains the reference standard for renal stones >2 cm when maximal single-session clearance is the principal objective. Modern RIRS increasingly represents a clinically relevant alternative in appropriately selected patients. Rather than defining a single superior procedure, contemporary management should integrate stone burden and complexity, patient comorbidity, treatment goals, available technology, and local expertise.
Related
- Endoscopic management of pancreatic duct stones and stricture in chronic pancreatitis using a fully covered self-expandable metal stent.
- Audit of Conservative Management of Acute Ureteric Stones and Factors Influencing Treatment Outcome in the Emergency Department
- Emergency Management of Obstructing Ureteric Stones: A Closed-Loop Audit of Hot Ureteroscopy Uptake Against Getting It Right First Time (GIRFT) Standards.
- Modern hysteroscopic management of congenital uterine anomalies: current techniques, emerging technologies, and future directions
- Modern craniopharyngioma management: three illustrative cases with distinct therapeutic strategies
BibTeX
@article{samira2026management,
title = {{Management of Renal Stones >2 cm in the Modern Endourology Era: Does PCNL Remain the Gold Standard?}},
author = {Nidal Samira and Murad Asali},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15207830},
url = {https://www.mdpi.com/2077-0383/15/20/7830},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Management of Renal Stones >2 cm in the Modern Endourology Era: Does PCNL Remain the Gold Standard?
AU - Nidal Samira
AU - Murad Asali
PY - 2026
DA - 2026/10/10
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15207830
UR - https://www.mdpi.com/2077-0383/15/20/7830
AB - Background: Percutaneous nephrolithotomy (PCNL) remains the reference treatment for renal stones larger than 2 cm because of its high single-session stone-free rate. However, advances in flexible ureteroscopy (fURS), laser lithotripsy, suction-assisted access systems, and endoscopic technology have expanded the role of retrograde intrarenal surgery (RIRS) in patients who historically would have been treated primarily with PCNL. Objective: To critically review the contemporary roles of PCNL and RIRS in the management of renal stones >2 cm and evaluate whether advances in endoscopic and laser technologies have altered the traditional treatment paradigm. Methods: A focused narrative review of the contemporary literature was performed using PubMed, Scopus, and Web of Science. Priority was given to randomized trials, prospective comparative studies, multicenter registries, systematic reviews, meta-analyses, and international guideline recommendations evaluating efficacy, safety, retreatment, operative burden, and technological developments relevant to the management of large renal stones. Results: PCNL continues to provide the most reliable single-session stone clearance for large and complex renal calculi, particularly in patients with high stone burden and staghorn disease. RIRS offers lower procedural morbidity and faster recovery but may require staged procedures as stone burden increases. Recent developments, including thulium fiber laser, pulse-modulated Holmium:YAG systems, suction-assisted ureteral access sheaths, improved digital ureteroscopy, and intrarenal pressure-control strategies, have increased the efficiency and potential applicability of RIRS for larger stones. Nevertheless, current evidence does not support replacing PCNL as the reference treatment for complex or high-volume stone disease. Conclusion: PCNL remains the reference standard for renal stones >2 cm when maximal single-session clearance is the principal objective. Modern RIRS increasingly represents a clinically relevant alternative in appropriately selected patients. Rather than defining a single superior procedure, contemporary management should integrate stone burden and complexity, patient comorbidity, treatment goals, available technology, and local expertise.
SN - 2077-0383
ER -